Bio-Path Holdings EBIT

As of the most recent data (March 2026), BPTH shows a EBIT of $-5.7M. That compares with $-5.7M in the prior-year period — down 1.5% year over year. That is below the Healthcare sector average of $22B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BPTH's EBIT is now $-5.7M (was $-5.7M) — a 1.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Path Holdings is outperforming or lagging.

The Healthcare sector average EBIT is about $22B. Bio-Path Holdings is at $-5.7M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how BPTH stacks up against individual peers as well.

Tracking BPTH's ebit over time shows whether Bio-Path Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $-5.7M That compares with $-5.7M in the prior-year period — down 1.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Bio-Path Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-5.7M) with ownership activity and broader fundamentals.